Track your Ozempic doses in Peptimes
Ozempic is Novo Nordisk's brand of semaglutide. Peptimes is a private iPhone tracker where you keep your own record of each Ozempic dose: when you took it, how you took it, and how you felt afterward.
The amounts and the schedule come from you, and Peptimes never suggests an amount. It doesn't sell anything. If you have a question about the medicine itself, your prescriber is the person to ask.
What Ozempic is
Ozempic is made by Novo Nordisk, and its active ingredient is semaglutide. In the US the name now covers two separate products, each on its own FDA application:
- Ozempic injection, under the skin (subcutaneous): its label lists single-patient-use pens, which hold several doses for one person, and single-dose prefilled syringes. FDA first approved it on December 5, 2017, under NDA 209637.
- Ozempic tablets: taken by mouth (oral). They sit on the same application as Rybelsus tablets, NDA 213051, and the two brands share one label.
Drugs@FDA lists one older Ozempic injection presentation as discontinued and the others as prescription products. We checked these details on DailyMed and Drugs@FDA on October 25, 2026.
Ozempic's US status
FDA Approved, for the uses in its label. Each Ozempic product has a label of its own, so read the one that matches yours on DailyMed: the Ozempic injection label or the Ozempic tablets label.
Prescription only. Drugs@FDA lists both the injection and the tablets as prescription products.
Compounded semaglutide isn't Ozempic. In FDA's words, "Compounded drugs are not FDA-approved," and a compounded product doesn't share Ozempic's approval just because it has the same active ingredient. An approval belongs to a specific product, route and use. See what "compounded" means.
Wegovy and Rybelsus are semaglutide too
Novo Nordisk also sells semaglutide as Wegovy (injections and tablets) and as Rybelsus tablets. Rybelsus tablets share one application and one label with Ozempic tablets; Wegovy has its own. The brands and ingredients guide lists each one from FDA's records.
Which brand you use, and any move from one to another, is your prescriber's decision. If it happens, keeping records when you switch medicines covers what to note so your history stays easy to follow.
Tracking Ozempic in Peptimes
Peptimes keeps one Library entry per active ingredient, so Ozempic is tracked as semaglutide. Search by a brand name such as Ozempic, and you'll find the entry for its active ingredient. To put it on your schedule, add semaglutide as a protocol: tap +, choose Add a Protocol, and search Ozempic or semaglutide. Then set the days and times you already follow.
Each time you log a dose, you record:
- the amount you took, which you type in yourself
- the route: subcutaneous for an injection, oral for the tablets
- the injection site, for injected doses only; tablet doses skip that step
- how you feel, as ratings and notes, if you want to
The protocol is shown as semaglutide. To keep the brand on record, write "Ozempic pen", "Ozempic syringe" or "Ozempic tablets" in a dose's Notes, and it appears on that dose's summary.
A reminder on each Ozempic day
Once your schedule is in, Peptimes sends one reminder per dose, at the dose time or a set number of minutes before it. If a dose still isn't logged, a "Not logged" follow-up arrives later; you can change its timing or turn it off.
Prefer that the lock screen says nothing about Ozempic? Turn on Discreet, and every dose reminder and its follow-up read only "You have a reminder" and "Open the app to see it."

Injected doses on the body map
Every injected dose you log with a site shows up in Insights, on a body map of where you've injected and how recently. It's history only, never where to inject next. Tablet doses have no site, so they never appear on it. Injection site history explains the map in full.

Your Ozempic history, ready for an appointment
Dose History lists every dose newest first; tap semaglutide to see only those. The Calendar shows the same doses by month, week or day, and lets you fill in one you forgot to log. If you choose, you can also keep a weight history and body measurements.
When you want a copy, export your records as CSV or JSON. Your health records are stored on your iPhone. Your records may not come across to a new iPhone, so export a copy first. More in how Peptimes handles your data.

FAQ
Can I track Ozempic tablets and Ozempic injections?
Yes. Both are semaglutide in Peptimes. Pick subcutaneous for an injection, pen or syringe, and oral for a tablet, and only injected doses ask for an injection site. Add "pen", "syringe" or "tablets" in the Notes if you want the form on record.
Is compounded semaglutide the same as Ozempic?
No. Ozempic is a specific Novo Nordisk product with its own FDA approval. FDA states that "Compounded drugs are not FDA-approved," and a compounded product doesn't take on Ozempic's approval.
Does Peptimes tell me my Ozempic dose?
No. You type in the amount your prescriber gave you, and Peptimes never suggests an amount. It records what you enter and reminds you at the times you set.
Is Ozempic the same product as Wegovy?
They share an active ingredient, semaglutide, but FDA approved them as separate products with separate labels. The brands and ingredients guide sets the brands side by side.
Price and availability
Coming soon to the App Store. Planned launch pricing: $9.99/month or $69.99/year, with a 14-day free trial. After the 14-day trial, Peptimes needs a subscription. See planned pricing.
Sources
- FDA, Drugs@FDA, NDA 209637 (Ozempic injection), checked 25 Oct 2026: applicant Novo Nordisk ("NOVO"), solution for subcutaneous use; original approval 12/05/2017; one presentation "Discontinued", the others "Prescription".
- FDA, Drugs@FDA, NDA 213051 (Ozempic and Rybelsus tablets), checked 25 Oct 2026: Ozempic and Rybelsus both listed as oral tablets on one application, "Prescription".
- NLM DailyMed, OZEMPIC (semaglutide) injection label, Novo Nordisk, version of June 2026, checked 25 Oct 2026: section 16, single-patient-use pens and single-dose prefilled syringes; "OZEMPIC is a registered trademark of Novo Nordisk A/S."
- NLM DailyMed, RYBELSUS and OZEMPIC (semaglutide) tablets label, Novo Nordisk, version of January 2026, checked 25 Oct 2026: one label for both brands; "RYBELSUS and OZEMPIC are registered trademarks of Novo Nordisk A/S."
- FDA, "Compounding and the FDA: Questions and Answers" (content current as of 09/16/2025), checked 25 Oct 2026: "Compounded drugs are not FDA-approved."
Ozempic, Wegovy and Rybelsus are trademarks of Novo Nordisk A/S. Peptimes isn't affiliated with or endorsed by Novo Nordisk.
Coming soon to the App Store
See planned pricing